TOP TIERMARKET NEWSWIRE
News & sentiment

PALVELLA THERAPEUTIC (PVLA) — News & AI sentiment

PALVELLA THERAPEUTIC (PVLA) news roundup. 2 stories in the past week, 7 over 30 days. Average 30-day sentiment is 62.4/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 4 sales totalling $1.8M — net selling of $1.8M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 63/100
30d stories
7
avg sentiment 62.4/100
Insider net (90d)
$1.8M
0 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

PVLA news in the last 24 hours, 7 days, 30 days and 90 days

How much PVLA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowPVLA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days263/100PVLA headlines →
Last 30 days762.4/100PVLA headlines →
Last 90 days2956.7/100PVLA headlines →

Latest stories on PVLA

4d ago
4d ago
Sep 2
Sep 2
Aug 31
Aug 31
Aug 19
Palvella (PVLA) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Aug 11
Aug 5
Aug 5
Aug 4
Aug 4
Aug 4
Aug 4
Aug 4
Aug 4
Jul 30
Jul 28
H.C. Wainwright reiterates Palvella Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Jul 22
Jul 15
Jul 14
Jun 30
Jun 30
Jun 30
Jun 29
Open PVLA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →